Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation
暂无分享,去创建一个
A. Wells | P. Doherty | A. Heagerty | Lora Capobianco | L. Davies | C. Heal | P. Fisher | D. Reeves
[1] A. Wells,et al. Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study , 2020, Frontiers in Psychiatry.
[2] A. Wells,et al. Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial , 2020, Scientific Reports.
[3] A. Wells. Breaking the Cybernetic Code: Understanding and Treating the Human Metacognitive Control System to Enhance Mental Health , 2019, Front. Psychol..
[4] J. Higgins,et al. Choosing effect measures and computing estimates of effect , 2019, Cochrane Handbook for Systematic Reviews of Interventions.
[5] S. Golder,et al. Determinants of depression in patients with comorbid depression following cardiac rehabilitation , 2019, Open Heart.
[6] P. Doherty,et al. Standards and core components for cardiovascular disease prevention and rehabilitation , 2019, Heart.
[7] A. Wells,et al. Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective? , 2019, Front. Psychol..
[8] N. Morina,et al. The Efficacy of Metacognitive Therapy: A Systematic Review and Meta-Analysis , 2018, Front. Psychol..
[9] O. Hjemdal,et al. Metacognitive therapy versus cognitive–behavioural therapy in adults with generalised anxiety disorder , 2018, BJPsych open.
[10] A. Wells,et al. Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial , 2018, Trials.
[11] W. Kraus,et al. Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial , 2016, Circulation.
[12] S. Beach,et al. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. , 2014, JAMA internal medicine.
[13] Faith Parsons,et al. Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. , 2013, JAMA internal medicine.
[14] T. Kohlmann,et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] H. Khalil. Psychological and pharmacological interventions for depression in patients with coronary artery disease , 2011 .
[16] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[17] S. Ebrahim,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.
[18] B. Thombs,et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. , 2011, General hospital psychiatry.
[19] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[20] Constantine Frangakis,et al. Multiple imputation by chained equations: what is it and how does it work? , 2011, International journal of methods in psychiatric research.
[21] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[22] Adrian Wells,et al. Metacognitive Therapy for Anxiety and Depression , 2008 .
[23] N. Frasure-smith,et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. , 2007, JAMA.
[24] R. Carney,et al. Depression and Late Mortality After Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study , 2004, Psychosomatic medicine.
[25] Adrian Wells,et al. A short form of the metacognitions questionnaire: properties of the MCQ-30. , 2004, Behaviour research and therapy.
[26] Marion K Campbell,et al. The method of minimization for allocation to clinical trials. a review. , 2002, Controlled clinical trials.
[27] T. T. Haug,et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.
[28] R C Littell,et al. Mixed Models: Modelling Covariance Structure in the Analysis of Repeated Measures Data , 2005 .
[29] G. Serban. Assessing Psychological Trauma and PTSD , 1999 .
[30] N. Jacobson,et al. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.
[31] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.
[32] M. Hotopf,et al. Depression and anxiety symptom trajectories in coronary heart disease: Associations with measures of disability and impact on 3-year health care costs. , 2018, Journal of psychosomatic research.
[33] Shah Ebrahim,et al. Psychological interventions for coronary heart disease. , 2012, The Cochrane database of systematic reviews.
[34] Helena Motlagh,et al. Impact of Event Scale-revised. , 2010, Journal of physiotherapy.
[35] C. Padesky,et al. Mind over mood: A cognitive therapy treatment manual for clients. , 1995 .